Stephen Ostroff
Stephen Ostroff | |
---|---|
Acting Commissioner of Food and Drugs | |
In office January 20, 2017 - May 11, 2017 | |
President | Donald Trump |
Preceded by | Robert Califf |
Succeeded by | Scott Gottlieb |
In office April 1, 2015 - February 22, 2016 | |
President | Barack Obama |
Preceded by | Margaret Hamburg |
Succeeded by | Robert Califf |
Deputy Commissioner for Food and Veterinary Medicine | |
In office April 1, 2015 – February 21, 2016 | |
President | Barack Obama |
Preceded by | Margaret Hamburg |
Succeeded by | Robert Califf |
Personal details | |
Born | Philadelphia, Pennsylvania, U.S. |
Alma mater | University of Pennsylvania |
Stephen Ostroff is an American physician. He served as acting commissioner of the U.S. Food and Drug Administration from April 1, 2015,[1] to February 21, 2016,[2] and from January to May 2017.[3]
Biography
[edit]Ostroff is a 1981 graduate of the University of Pennsylvania of Medicine. He completed residencies in internal medicine at the University of Colorado Health Sciences Center and in preventive medicine at Centers for Disease Control and Prevention (CDC). He worked at the CDC, the US Public Health Service, and at the Bureau of Epidemiology of Pennsylvania. In 2013, Ostroff joined the FDA as chief medical officer in the Center for Food Safety and Applied Nutrition and senior public health advisor to FDA's Office of Foods and Veterinary Medicine and was promoted to chief scientist in 2014.[3]
References
[edit]- ^ "FDA head Margaret Hamburg to resign in March". The Washington Post.
- ^ "Califf Wins Senate Confirmation Vote on FDA Top Spot". Medscape. February 24, 2016. Retrieved 2016-02-24.
- ^ a b Commissioner, Office of the. "FDA Organization - Meet Stephen Ostroff, M.D., Acting Commissioner of Food and Drugs". Food and Drug Administration. Archived from the original on December 18, 2019.